Short answer · Medically reviewed summary · Last updated: 2026-05-08
Seasonal Affective Disorder (SAD) was formally identified and named in 1984 by Dr. Norman Rosenthal and his colleagues at the National Institute of Mental Health.
Seasonal Affective Disorder (SAD) was formally identified and named in 1984 by Dr. Norman Rosenthal and his colleagues at the National Institute of Mental Health. While historical accounts of "winter blues" date back to ancient times, the modern clinical characterization of Seasonal Affective Disorder established it as a recurring major depressive disorder linked to seasonal changes in light exposure.
Although physicians like Hippocrates and later 19th-century explorers of the Arctic noted mood shifts during long, dark winters, the scientific foundation for Seasonal Affective Disorder emerged in the early 1980s. Dr. Norman Rosenthal, who personally experienced seasonal mood changes, led the landmark study that moved the condition from folklore to a recognized diagnostic entity. His research demonstrated that specific photoperiodic changes influence human neurobiology, mirroring the behaviors observed in hibernating animals.
The evolution of Seasonal Affective Disorder research has shifted from purely psychiatric observation to complex neurobiological investigation. Researchers now understand that the condition is not merely a "bad mood," but involves dysregulation of neurotransmitters like serotonin and melatonin, which are governed by the body's circadian rhythms. Modern technology, including functional MRI and genetic sequencing, has helped researchers identify potential predispositions that make some individuals more sensitive to light deprivation than others.
The history of treating Seasonal Affective Disorder is defined by the development of specialized light therapy, which remains the gold standard. Key milestones include:
Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment.